Featured Coverage | Amicus Therapeutics

Featured Coverage


AMICUS HAS BEEN NAMED ONE OF THE 2018 BEST PLACES TO WORK IN JERSEY

NJBIZ Announces the 2018 Best Places to Work in New Jersey!

Amicus Therapeutics has been named one of the 2018 Best Places to Work in New Jersey in the medium-sized company category. This survey and awards program identifies, recognizes and honors the top places of employment in New Jersey that benefit the state’s economy, workforce and businesses.

For more information on the Best Places to Work in New Jersey program  please visit www.njbiz.com/events.


Healing Beyond Disease Featured in PharmaVOICE April 2018

Amicus launches Healing Beyond Disease, a global, employee-driven initiative inspired by people living with rare diseases and their families. View article.

Amicus Healing Beyond Disease

 

 

 

 

 

 


Dr. Jay Barth, Chief Medical Officer, Featured in Pharmavoice October 2017

A Rare Jouney: Managing the Regulatory Landscape. View Article.

Amicus Therapeutic's Jay Barth featured in Pharmavoice

 

 

 

 

 

 

 

 

 

 


JOHN CROWLEY, CHAIRMAN AND CEO, FEATURED ON FOX BUSINESS MORNINGS WTH MARIA

Amicus Therapeutics CEO John Crowley on how his fight to find a treatment for his children’s rare disease, Pompe, has driven his work in the pharmaceutical industry. View video.

JOHN CROWLEY, CHAIRMAN AND CEO, FEATURED ON FOX BUSINESS MORNINGS WTH MARIA

 

 

 

 

 


JOHN CROWLEY, CHAIRMAN AND CEO, FEATURED ON CNBC

Amicus Chairman and Chief Executive Officer John Crowley says treatment for Pompe disease could be the crown jewel of the company. View video.

JOHN CROWLEY, CHAIRMAN AND CEO, FEATURED ON CNBC

 

 

 

 

 


One Dad's 14-year Quest For Cure

By GEETA ANAND

Seven months ago, Megan Crowley made a gutsy decision: to undergo a radical surgery to straighten out her spine, which has been crippled by Pompe disease. Photo: Lexey Swall

Click Here to Read the Article

Click Here to View the Video


Amicus Therapeutics CEO: Driving Science to a Cure

John Crowley, Amicus Therapeutics chairman and CEO, discusses its Fabry pill development and next generation therapy for Pompe disease, with CNBC’s Jim Cramer.

Click Here to Read the Article


Amicus Therapeutics (FOLD) CEO John Crowley 'Squawk Box' on CNBC


Biotechnology Requires Massive Investment: CEO John Crowley

John Crowley, CEO of Amicus Therapeutics, discusses his biotechnology business model, as well as drugs pricing.


Amicus Coo Bradley Campbell Featured In Parmavoice

Mr. Campbell discusses how engagement with rare disease advocacy groups has helped Amicus build trust with patients and families. View article.


Amicus Hosts CabaRare

Amicus hosted a CabaRare to showcase entertainers living with rare diseases in honor of Rare Disease Day 2017.


Enrique Diloné, Senior VP of Technical Operations, Featured in Pharmavoice Supply Chain Report

Dr. Diloné discusses the unique and complex challenges in getting a therapy to geographically dispersed rare disease patients. View article.

Investor/
Media Contact

Sara Pellegrino
 609-662-5000
 ir@amicusrx.com